| 注册
首页|期刊导航|肿瘤药学|DNA 异常甲基化及其在宫颈腺癌中作用的研究进展

DNA 异常甲基化及其在宫颈腺癌中作用的研究进展

赵雪蘅 王静 唐雁 方凯宁 赵敏

肿瘤药学2016,Vol.6Issue(2):103-107,5.
肿瘤药学2016,Vol.6Issue(2):103-107,5.DOI:10.3969/j.issn.2095-1264.2016.02.04

DNA 异常甲基化及其在宫颈腺癌中作用的研究进展

Abnormal DNA Methylation in the Development of Cervical Adenocarcinoma

赵雪蘅 1王静 2唐雁 1方凯宁 1赵敏3

作者信息

  • 1. 南华大学,湖南 衡阳,421001
  • 2. 湖南省肿瘤医院 / 中南大学湘雅医学院附属肿瘤医院,湖南 长沙,410013
  • 3. 中南大学湘雅医院临床药理研究所,湖南 长沙,410008
  • 折叠

摘要

Abstract

Cancer is a complex disease resulting from genetic and epigenetic abnormality. According to the present researches, epigenetic modification is of practical significance in the occurrence and development of tumors, mainly in the change of DNA methylation, regulation of miRNA expression, histone modifications, activation of oncogene, silence of tumor suppressor genes and so on. Aberrant DNA methylation influences chromatin configuration and expression of oncogene and tumor suppressor genes, thus involving in tumorigenesis. Comprehensive knowledge of the research progress in Cervical Adenocarcinoma DNA methylation could not only make help in early diagnosis of the disease, but also have great clinical value in the targeted treatment and prognosis assessment.

关键词

抑癌基因/DNA 甲基化/表观遗传学/宫颈腺癌

Key words

Cancer suppressor genes/DNA methylation/Epigenetics/Cervical adenocarcinoma

分类

医药卫生

引用本文复制引用

赵雪蘅,王静,唐雁,方凯宁,赵敏..DNA 异常甲基化及其在宫颈腺癌中作用的研究进展[J].肿瘤药学,2016,6(2):103-107,5.

肿瘤药学

OACSTPCD

2095-1264

访问量0
|
下载量0
段落导航相关论文